Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021)
Dentsply Sirona's (XRAY) quarterly Current Deferred Revenue came in at $68.0 million in Q4 2021, up 28.3% YoY from $53.0 million in Q4 2020, and up 28.3% on a QoQ basis from $53.0 million in Q4 2020.
Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021) Analysis & Trends
Dentsply Sirona (XRAY) has 4 years of Current Deferred Revenue data on file, last reported at $68.0 million in Q4 2021.
- Quarterly Current Deferred Revenue rose 28.3% year-over-year to $68.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $68.0 million (up 28.3% YoY) and the FY2021 annual result came in at $68.0 million, up 28.3% from the prior year.
- Current Deferred Revenue grew to $68.0 million in Q4 2021, from $53.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $68.0 million in Q4 2021 to a low of $53.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Dentsply Sirona | 2.18 Bn | 1.94 Bn | 493.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 68.00 Mn |
| Dec 31, 2020 | 53.00 Mn |
| Dec 31, 2010 | 5.66 Mn |
| Dec 31, 2009 | 3.39 Mn |